US FDA may inspect Sun Pharma’s Halol site in February: Sources

MUMBAI: The US Food and Drug Administration is expected to begin inspection of Sun Pharma’s manufacturing facility at Halol in the second week of February, sources told ET. The much-awaited inspection is critical as the facility produces multiple medicines from tablets to ointments and injectables.